On average, 17.5 million adults were diagnosed with depression disorder each year during the period 2005–2016. The majority were female (67.9%), a larger proportion of whom received antidepressant medications (60.5% vs. 51.5% of males). Although use of antidepressants was associated with some improvement on the MCS, D-I-D univariate analysis revealed no significant difference between the two cohorts in PCS (–0.35 vs. –0.34, p = 0.9595) or MCS (1.28 vs. 1.13, p = 0.6405). The multivariate D-I-D analyses ensured the robustness of these results. 

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265928

Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States “Despite the empirical literature demonstrating the efficacy of antidepressant medications for treatment of depression disorder, these medications’ effect on patients’ overall well-being and health-related quality of life (HRQoL) remains controversial. This study investigates the effect of antidepressant medication use on patient-reported HRQoL for patients who have depression.” journals.plos.org



In English, no significant improvement. “People who use drugs intended to treat depression long-term do not see improvements in their overall physical and mental well-being compared with those who avoid taking antidepressants, a study published Wednesday found.”https://www.upi.com/Health_News/2022/04/20/depression-treatment-prescription-drugs-study/1101650468658/